3.12 (3.99%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Neutral
Earnings
Very Strong
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Strong
Website
Apogee Therapeutics, Inc.
Telephone
1.650.394.5230
Address
Suite 102b, Building 17, 221 Crescent Street, Waltham, MA 02453
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 34.34 - 95.32
Trade Value (12mth)
US$13,064,182.00
1 week
-3.54%
1 month
-13.86%
YTD
3.29%
1 year
94.8%
All time high
95.32
EPS 3 yr Growth
436.90%
EBITDA Margin
0.00%
Operating Cashflow
-$227m
Free Cash Flow Return
-27.80%
ROIC
-31.30%
Interest Coverage
0.00
Quick Ratio
26.60
Shares Outstanding (Fully Diluted)
70m
HALO Sector
Healthcare
Next Company Report Date
08-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 11 May 26 | |
| 11 May 26 | |
| 11 May 26 | |
| 11 May 26 | |
| 25 April 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -1.66 | -3.3 | -4.22 | | | | ||
EPS (Fully Diluted) | $ | | | | | -1.66 | -3.3 | -4.22 | | | | ||
Growth | % | | | | | -111.2 | -99 | -27.7 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
